Gene therapy treatment gives new hope to sickle cell patients
Only a few patients have undergone an intensive gene therapy cure for sickle cell disease since it was approved by the FDA due to it's high cost and limited access. NBC News' Yamiche Alcindor spoke ...
cidrap.umn52m
New guidelines expand recommendations for shorter, all-oral TB treatments
The guidelines recommend a 4-month drug regimen for adults and children with drug-susceptible TB, and a 6-month regimen for those with drug-resistant TB.